Skip to content

Search Results

756 Results

Justice-Involved Individuals, Mental Health, and the Revolving Door

  • Patients and Families, Serious mental illness, Treatment

On Sept. 20, 2022, the U.S. Preventative Services Task Force (USPSTF) released a draft statement recommending that U.S. adults under the age of 65 should be screened for anxiety 1. This recommendation underscores the emerging need for the inclusion of mental health screens as a part of everyday clinical practice and not simply reserved for behavioral health settings. More widespread screening will better inform treatment decisions, lead to referrals for care, and slow down, or in some cases even

Colleges Increase Their Focus on Student Mental Health

  • Anxiety, Depression, Patients and Families

As many students head back to college this fall, a new survey finds that student mental health is getting more attention among college leaders. Eight out of 10 colleges are placing a greater priority on student mental health now compared to three years ago, according to a recent survey of college presidents from the American Council on Education. Most college presidents said their staff and faculty are spending more time addressing mental health concerns that three years ago. More than 70%, of t

Warm Lines: Providing Help Before a Crisis Develops

  • Patients and Families

A warm line is a confidential, free phone service offering mental health support. Unlike a crisis line or hotline, they are not intended for emergency situations. Warm lines are typically staffed by volunteer or paid peers—people with personal experience with mental health disorders.  They use their experience to better understand and support callers, offering conversation, emotional support and information on local mental health services and other community services when needed.

Study Supports Effectiveness of New Fast-Acting Antidepressant, Esketamine Nasal Spray

New research supports the effectiveness and safety of esketamine nasal spray in treating depression in people who have not responded to previous treatment. The research will be published online today in the American Journal of Psychiatry. This study is one of the key studies that led to the recent Food and Drug Administration (FDA) approval of esketamine nasal spray, in conjunction with an oral antidepressant, for use in people with treatment-resistant depression.

Personal Perspectives on Family Engagement and Support

Ken Duckworth, M.D., chief medical officer, National Alliance on Mental Illness (NAMI) leads a deep discussion with individuals who reflect on their years of lived experience with serious mental illness (SMI) and the critical role family members played in their journeys.

Lessons from Rapid Expansion of Telemedicine During the Pandemic

  • Patients and Families

Widespread lockdowns earlier this year in response to COVID-19  pandemic led to the rapid use of telehealth. A recent study in the Journal of Adolescent Health focused on  one health clinic in California serving adolescents and young adults as they rapidly transitioned to telehealth. As was the situation across the country,  the clinic went from 0 to almost all (97%) of patient visits occurring via telehealth within a month.

Medical leadership for mind, brain and body.

Join Today